GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shafa Darou Pharmaceutical Investment Co (XTEH:SHFA1) » Definitions » Interest Expense

Shafa Darou Pharmaceutical Investment Co (XTEH:SHFA1) Interest Expense : IRR Mil (TTM As of . 20)


View and export this data going back to 2018. Start your Free Trial

What is Shafa Darou Pharmaceutical Investment Co Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Shafa Darou Pharmaceutical Investment Co's interest expense for the six months ended in . 20 was IRR 0.00 Mil. Shafa Darou Pharmaceutical Investment Co does not have enough years/quarters to calculate its interest expense for the trailing twelve months (TTM) ended in . 20.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Shafa Darou Pharmaceutical Investment Co's Operating Income for the six months ended in . 20 was IRR 0.00 Mil. Shafa Darou Pharmaceutical Investment Co's Interest Expense for the six months ended in . 20 was IRR 0.00 Mil. Shafa Darou Pharmaceutical Investment Co did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.


Shafa Darou Pharmaceutical Investment Co Interest Expense Historical Data

The historical data trend for Shafa Darou Pharmaceutical Investment Co's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shafa Darou Pharmaceutical Investment Co Interest Expense Chart

Shafa Darou Pharmaceutical Investment Co Annual Data
Trend
Interest Expense

Shafa Darou Pharmaceutical Investment Co Semi-Annual Data
Interest Expense

Shafa Darou Pharmaceutical Investment Co Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.


Shafa Darou Pharmaceutical Investment Co  (XTEH:SHFA1) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Shafa Darou Pharmaceutical Investment Co's Interest Expense for the six months ended in . 20 was IRR0.00 Mil. Its Operating Income for the six months ended in . 20 was IRR0.00 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in . 20 was IRR0.00 Mil.

Shafa Darou Pharmaceutical Investment Co's Interest Coverage for the quarter that ended in . 20 is calculated as

Shafa Darou Pharmaceutical Investment Co had no long-term debt (1).

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.


Shafa Darou Pharmaceutical Investment Co (XTEH:SHFA1) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
Fakhar Moghadam Street, Dadman Street, No. 13, At the corner of East 4th Golbarg Alley, Shahrak-e Gharb, Tehran, IRN
Shafa Darou Pharmaceutical Investment Co is a pharmaceutical holding company. Along with its subsidiaries it produces injectable, non-injectable, and antibiotics.

Shafa Darou Pharmaceutical Investment Co (XTEH:SHFA1) Headlines

No Headlines